2025-08-29 01:29:38
Latest Post
Himadri Speciality Chemical Ltd Secures ISCC PLUS Certification
HCLSoftware delivers Digital Independence with AI-Powered Sovereign Collaboration Solutions for Business-Critical Infrastructure
Dr. Agarwal's Health Care Limited and Dr. Agarwal's Eye Hospital Limited announce Merger
SAMHI signs agreement to Lease for ~260-room Mid-Scale Hotel in Hyderabad's Financial District
Rail Vikas Nigam Ltd signs JV agreement with Texmaco Rail & Engineering Ltd
Stock Report
Metropolis Healthcare Ltd posts consolidated PAT of Rs. 35.79 crores in Q3 FY2023
Posted On : 2023-02-12 07:57:36( TIMEZONE : IST )
Metropolis Healthcare Limited has reported Consolidated financial results for the period ended December 31, 2022.
Financial Results (Q3 FY2023) - QoQ Comparison
The company has reported total income of Rs. 292.0807 crores during the period ended December 31, 2022 as compared to Rs. 304.6844 crores during the period ended September 30, 2022.
The company has posted net profit / (loss) of Rs. 35.7987 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs. 40.3313 crores for the period ended September 30, 2022.
The company has reported EPS of Rs. 6.97 for the period ended December 31, 2022 as compared to Rs. 7.85 for the period ended September 30, 2022.
| Financials | Q3 FY2023 | Q2 FY2023 | % Change |
| Total Income | ₹292.0807 crs | ₹304.6844 crs |  -4.14% |
| Net Profit | ₹35.7987 crs | ₹40.3313 crs | -11.24% |
| EPS | ₹6.97 | ₹7.85 | -11.21% |
Financial Results (Q3 FY2023) - YoY Comparison
The company has reported total income of Rs.292.0807 crores during the period ended December 31, 2022 as compared to Rs.295.6628 crores during the period ended December 31, 2021.
The company has posted net profit / (loss) of Rs.35.7987 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs.41.0388 crores for the period ended December 31, 2021.
The company has reported EPS of Rs.6.97 for the period ended December 31, 2022 as compared to Rs.7.98 for the period ended December 31, 2021.
| Financials | Q3 FY2023 | Q3 FY2022 | % Change |
| Total Income | ₹292.0807 crs | ₹295.6628 crs | -1.21% |
| Net Profit | ₹35.7987 crs | ₹41.0388 crs | -12.77% |
| EPS | ₹6.97 | ₹7.98 | -12.66% |
Financial Results (9 Months Ended FY2023) - YoY Comparison
The company has reported total income of Rs.879.6626 crores during the 9 Months period ended December 31, 2022 as compared to Rs.934.3828 crores during the 9 Months period ended December 31, 2021.
The company has posted net profit / (loss) of Rs.109.5273 crores for the 9 Months period ended December 31, 2022 as against net profit / (loss) of Rs.174.1953 crores for the 9 Months period ended December 31, 2021.
The company has reported EPS of Rs.21.31 for the 9 Months period ended December 31, 2022 as compared to Rs.33.88 for the 9 Months period ended December 31, 2021.
| Financials | 9 Months Ended FY2023 | 9 Months Ended FY2022 | % Change |
| Total Income | ₹879.6626 crs | ₹934.3828 crs | -5.86% |
| Net Profit | ₹109.5273 crs | ₹174.1953 crs | -37.12% |
| EPS | ₹21.31 | ₹33.88 | -37.10% |
Shares of Metropolis Healthcare Limited was last trading in BSE at Rs. 1282.65 as compared to the previous close of Rs. 1289.35. The total number of shares traded during the day was 5643 in over 943 trades.
The stock hit an intraday high of Rs. 1291.50 and intraday low of 1257.30. The net turnover during the day was Rs. 7217699.00.
